96 results
6-K
EX-99.1
TAK
Takeda Pharmaceutical Co
17 Dec 20
Current report (foreign)
6:01am
purpose-led and values-based approach. We hear from external stakeholders that we’re unique in the way we build this approach into our early access programs … , including our free “named patient programs” to help provide better access to medicines that are not available to people in their own countries
6-K
EX-99.1
TAK
Takeda Pharmaceutical Co
29 Jun 21
Current report (foreign)
7:38am
ACCESS: Our Access to Medicines programs operate in 54 countries and territories around the world and have provided treatment to more than 70,000 patients2 … to bring medicines and vaccines of the highest quality to patients as quickly as possible. Accelerate access to improve lives worldwide We partner
6-K
EX-99.1
TAK
Takeda Pharmaceutical Co
10 Jan 20
Better Health, Brighter Future 2019 SUSTAINABLE VALUE REPORT Takeda Pharmaceutical Company Limited
6:36am
, a global pharmaceutical company. This increase access to our innovative medicines to everyone acquisition enhanced our international footprint, who … evolving healthcare systems and expand patient access to these systems. We are aware, however, that the value we create is offset The multipliers used
6-K
EX-99.1
TAK
Takeda Pharmaceutical Co
6 Jul 23
Current report (foreign)
6:18am
with limited access to health care. For more than 70 years, Takeda has focused on vaccine development, most recently by being at the forefront of innovation … are prioritizing countries with the highest burden of disease and where barriers to access for vaccines are particularly complex. We have challenged and empowered
SC TO-T/A
EX-99
Trean Insurance Group Inc.
6 Jun 18
Third party tender offer statement (amended)
4:39pm
affiliates, represents or gives access to 90.83% of the voting rights represented or given access to by all of the outstanding Securities on a fully … ) and 90.83% of the voting rights represented or given access to by all the Ordinary Shares, Warrants and ADSs on a fully diluted basis as of the expiration
6-K
15lhqznkl5xz
29 May 20
Current report (foreign)
6:20am
6-K
EX-99.1
5ze0j
30 May 23
Current report (foreign)
6:19am
SC TO-T/A
EX-99
428hmrcgoukhkx 1oo
23 May 18
Third party tender offer statement (amended)
6:09am
6-K
EX-99.2
r2gyjmi
21 Nov 19
Current report (foreign)
6:08am
6-K
o69a38 wv0k
14 Jan 20
Current report (foreign)
6:56am
6-K
madnt z1zjxxp43l2u
26 Feb 21
Current report (foreign)
6:01am
6-K
i0obv mtme35q
27 May 20
Current report (foreign)
6:12am
6-K
EX-99.1
xm5 b3dfo0
15 Nov 19
Current report (foreign)
6:24am
6-K
a3cuxfw5nh4 7h
29 Oct 20
Current report (foreign)
6:04am
SC TO-T
EX-99
36d2r
30 Apr 18
Third party tender offer statement
6:13am
6-K
EX-99.1
xxq1b
31 May 22
Current report (foreign)
6:14am
SC TO-T
EX-99
ilzvfz7gospgz9
30 Apr 18
Third party tender offer statement
6:13am
6-K
EX-99.1
h9duq3um
28 May 21
Current report (foreign)
6:04am
SC TO-T
EX-99
k6lz42
30 Apr 18
Third party tender offer statement
6:13am